Literature DB >> 22252803

The natural antimicrobial peptide subtilosin acts synergistically with glycerol monolaurate, lauric arginate, and ε-poly-L-lysine against bacterial vaginosis-associated pathogens but not human lactobacilli.

Katia Sutyak Noll1, Mark N Prichard, Arkady Khaykin, Patrick J Sinko, Michael L Chikindas.   

Abstract

Subtilosin is a cyclical antimicrobial peptide produced by Bacillus amyloliquefaciens that has antimicrobial activity against the bacterial vaginosis-associated human pathogen Gardnerella vaginalis. The ability of subtilosin to inhibit G. vaginalis alone and in combination with the natural antimicrobial agents glycerol monolaurate (Lauricidin), lauric arginate, and ε-poly-L-lysine was tested using a checkerboard approach. Subtilosin was found to act synergistically with all of the chosen antimicrobials. These promising results indicate that lower concentrations of subtilosin in combination with other compounds could effectively be used to inhibit growth of the pathogen, thereby decreasing the risk of developed antimicrobial resistance. This is the first report on the effects of subtilosin combined with other natural antimicrobials against G. vaginalis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22252803      PMCID: PMC3318360          DOI: 10.1128/AAC.05861-11

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  40 in total

Review 1.  Bacterial vaginosis: more questions than answers.

Authors:  Erica Weir
Journal:  CMAJ       Date:  2004-08-31       Impact factor: 8.262

2.  Comparative activity of eighteen antimicrobial agents against anaerobic bacteria isolated in South Africa.

Authors:  M M Lubbe; P L Botha; L J Chalkley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-01       Impact factor: 3.267

3.  Epsilon-poly-L-lysine and nisin A act synergistically against Gram-positive food-borne pathogens Bacillus cereus and Listeria monocytogenes.

Authors:  M Badaoui Najjar; D Kashtanov; M L Chikindas
Journal:  Lett Appl Microbiol       Date:  2007-07       Impact factor: 2.858

4.  Isolation of the Bacillus subtilis antimicrobial peptide subtilosin from the dairy product-derived Bacillus amyloliquefaciens.

Authors:  K E Sutyak; R E Wirawan; A A Aroutcheva; M L Chikindas
Journal:  J Appl Microbiol       Date:  2007-11-01       Impact factor: 3.772

5.  Bacterial vaginosis and preterm birth: a prospective community-based cohort study.

Authors:  Pippa Oakeshott; Sally Kerry; Sima Hay; Philip Hay
Journal:  Br J Gen Pract       Date:  2004-02       Impact factor: 5.386

6.  HIV infection and disturbances of vaginal flora during pregnancy.

Authors:  T E Taha; R H Gray; N I Kumwenda; D R Hoover; L A Mtimavalye; G N Liomba; J D Chiphangwi; G A Dallabetta; P G Miotti
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1999-01-01

7.  Subtilosin A, a new antibiotic peptide produced by Bacillus subtilis 168: isolation, structural analysis, and biogenesis.

Authors:  K Babasaki; T Takao; Y Shimonishi; K Kurahashi
Journal:  J Biochem       Date:  1985-09       Impact factor: 3.387

8.  Structure of subtilosin A, a cyclic antimicrobial peptide from Bacillus subtilis with unusual sulfur to alpha-carbon cross-links: formation and reduction of alpha-thio-alpha-amino acid derivatives.

Authors:  Karen E Kawulka; Tara Sprules; Christopher M Diaper; Randy M Whittal; Ryan T McKay; Pascal Mercier; Peter Zuber; John C Vederas
Journal:  Biochemistry       Date:  2004-03-30       Impact factor: 3.162

9.  Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group.

Authors:  S L Hillier; R P Nugent; D A Eschenbach; M A Krohn; R S Gibbs; D H Martin; M F Cotch; R Edelman; J G Pastorek; A V Rao
Journal:  N Engl J Med       Date:  1995-12-28       Impact factor: 91.245

Review 10.  Maternal infection and adverse fetal and neonatal outcomes.

Authors:  Robert L Goldenberg; Jennifer F Culhane; Derek C Johnson
Journal:  Clin Perinatol       Date:  2005-09       Impact factor: 3.430

View more
  14 in total

1.  Antimicrobial Activity of Bacillus subtilis KATMIRA1933 and Bacillus amyloliquefaciens B-1895 Against Staphylococcus aureus Biofilms Isolated from Wound Infection.

Authors:  Ammar Algburi; Halah M Al-Hasani; Thurya K Ismael; Alyaa Abdelhameed; Richard Weeks; Aleksey M Ermakov; Michael L Chikindas
Journal:  Probiotics Antimicrob Proteins       Date:  2021-02       Impact factor: 4.609

2.  Polyethylene glycol-based hydrogels for controlled release of the antimicrobial subtilosin for prophylaxis of bacterial vaginosis.

Authors:  Sujata Sundara Rajan; Veronica L Cavera; Xiaoping Zhang; Yashveer Singh; Michael L Chikindas; Patrick J Sinko
Journal:  Antimicrob Agents Chemother       Date:  2014-02-24       Impact factor: 5.191

Review 3.  Bacteriocins - a viable alternative to antibiotics?

Authors:  Paul D Cotter; R Paul Ross; Colin Hill
Journal:  Nat Rev Microbiol       Date:  2012-12-24       Impact factor: 60.633

Review 4.  Anti-infective properties of bacteriocins: an update.

Authors:  Riadh Hammami; Benoit Fernandez; Christophe Lacroix; Ismail Fliss
Journal:  Cell Mol Life Sci       Date:  2012-10-30       Impact factor: 9.261

5.  The Natural Antimicrobial Subtilosin A Synergizes with Lauramide Arginine Ethyl Ester (LAE), ε-Poly-L-lysine (Polylysine), Clindamycin Phosphate and Metronidazole, Against the Vaginal Pathogen Gardnerella vaginalis.

Authors:  Veronica L Cavera; Anna Volski; Michael L Chikindas
Journal:  Probiotics Antimicrob Proteins       Date:  2015-06       Impact factor: 4.609

6.  Antibacterial synergy of glycerol monolaurate and aminoglycosides in Staphylococcus aureus biofilms.

Authors:  Donavon J Hess; Michelle J Henry-Stanley; Carol L Wells
Journal:  Antimicrob Agents Chemother       Date:  2014-09-02       Impact factor: 5.191

7.  Glycerol monolaurate nanocapsules for biomedical applications: in vitro toxicological studies.

Authors:  Leonardo Quintana Soares Lopes; Pablo Sebastian Britto de Oliveira; Walter Paixão de Souza Filho; Rodrigo de Almeida Vaucher; Janice Luehring Giongo; Michele Rorato Sagrillo; Roberto Christ Vianna Santos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-05-11       Impact factor: 3.000

8.  Subtilosin Prevents Biofilm Formation by Inhibiting Bacterial Quorum Sensing.

Authors:  Ammar Algburi; Saskia Zehm; Victoria Netrebov; Anzhelica B Bren; Vladimir Chistyakov; Michael L Chikindas
Journal:  Probiotics Antimicrob Proteins       Date:  2017-03       Impact factor: 4.609

9.  Antiherpes simplex virus type 2 activity of the antimicrobial peptide subtilosin.

Authors:  V M Quintana; N I Torres; M B Wachsman; P J Sinko; V Castilla; M Chikindas
Journal:  J Appl Microbiol       Date:  2014-08-23       Impact factor: 3.772

10.  Susceptibility of Gardnerella vaginalis biofilms to natural antimicrobials subtilosin, ε-poly-L-lysine, and lauramide arginine ethyl ester.

Authors:  Yevgeniy Turovskiy; Thomson Cheryian; Ammar Algburi; Ruth E Wirawan; Paul Takhistov; Patrick J Sinko; Michael L Chikindas
Journal:  Infect Dis Obstet Gynecol       Date:  2012-09-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.